Compare SYY & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYY | GEHC |
|---|---|---|
| Founded | 1969 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1B | 29.1B |
| IPO Year | 2003 | 2022 |
| Metric | SYY | GEHC |
|---|---|---|
| Price | $80.06 | $64.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $87.62 | ★ $88.38 |
| AVG Volume (30 Days) | 2.8M | ★ 4.5M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.97% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | ★ 2.51 | 0.85 |
| Revenue | ★ $81,370,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $4.83 | $7.12 |
| Revenue Next Year | $4.96 | $4.45 |
| P/E Ratio | ★ $31.29 | $75.01 |
| Revenue Growth | 3.20 | ★ 4.84 |
| 52 Week Low | $68.19 | $58.75 |
| 52 Week High | $91.85 | $89.77 |
| Indicator | SYY | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 68.03 | 51.47 |
| Support Level | $72.04 | $60.80 |
| Resistance Level | $83.07 | $64.99 |
| Average True Range (ATR) | 1.51 | 1.58 |
| MACD | 0.55 | 0.47 |
| Stochastic Oscillator | 99.72 | 68.13 |
Sysco is the largest US foodservice distributor with 18% share of the highly fragmented $377 billion domestic market. It distributes roughly 500,000 food and nonfood products to restaurants (60% of fiscal 2025 revenue), education and government buildings (8%), healthcare facilities (8%), travel and leisure (7%), and other locations (17%) where individuals consume away-from-home meals. In fiscal 2025, 70% of the firm's revenue was derived from its US foodservice operations, while its international (18%), quick-service logistics (10%), and other (2%) segments contributed the rest.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).